Product
Zavicefta
Aliases
Zavicefta, Ceftazidime-Avibactam
2 clinical trials
7 indications
Indication
PyelonephritisIndication
Hospital-Acquired PneumoniaIndication
Ventilator-associated pneumoniaIndication
BacteremiaIndication
Intra-abdominal infectionIndication
Urinary Tract InfectionIndication
PneumoniaClinical trial
AN OPEN-LABEL, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED STUDY TO ESTIMATE THE EFFICACY AND SAFETY OF CEFTAZIDIME-AVIBACTAM (CAZ-AVI) VERSUS BEST AVAILABLE TREATMENT (BAT) IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT GRAM-NEGATIVE PATHOGENS IN CHINESE ADULTSStatus: Completed, Estimated PCD: 2023-08-31
Clinical trial
A SINGLE ARM, OPEN-LABEL, MULTI-CENTER, INTERVENTIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF CEFTAZIDIME-AVIBACTAM (CAZ-AVI) IN CHINESE ADULTS WITH HAP (INCLUDING VAP)Status: Completed, Estimated PCD: 2023-05-04